top of page

AffloVest, a tried, true and proven airway clearance therapy with more than 10,000 already in clinical use, is the first battery-operated High Frequency Chest Wall Oscillation (HFCWO) therapy that let patients with bronchiectasiscystic fibrosis, and neuromuscular diseases receive state-of-the-art airway clearance therapy on the go.

Featuring Patented Direct Dynamic Oscillation™, AffloVest has eight mechanical oscillating motors scientifically engineered to target all 5 lobes of the lungs, front and back, for fully mobile during use. With no bulky hoses or generators, the AffloVest is engineered to encourage treatment adherence and compliance by allowing patients to experience an improved quality of life during airway clearance treatments.

  • First during-use HFCWO fully mobile Airway Clearance Therapy

  • Anatomically targets all 5 lobes of the lungs, both front and back

  • Promotes airway clearance and secretion mobilization

  • Clinically improved lung function shown in clinical studies

 

Airway Clearance Therapy

 

Diseases such as COPD, bronchiectasis, cystic fibrosis, quadriplegia and other neuromuscular disorders can reduce lung function, increase mucus production and interfere with proper breathing. Increased mucus production and retention of excess mucus increase the risk of lung infections.

Effectively clearing mucus from the air passages is extremely important. Airway clearance therapy using traditional manual chest physiotherapy or HFCWO vest therapy can provide improvement both in pulmonary function and quality of life in patients with chronic hyper-secretive diseases.

HFCWO vest therapy can help loosen thick mucus secretions so it can be mobilized from your lungs by coughing. Clearing the airways may help decrease lung infections, reduce antibiotic use and hospitalization, and improve lung function.

The goals of AffloVest mechanical HFCWO therapy are to reduce the number of exacerbations and infections and to improve patient quality of life by reducing airway inflammation and mobilizing secretions.

 

AffloVest can be prescribed for:

  • Bronchiectasis

  • Cystic Fibrosis

  • Late Effects of poliomyelitis

  • Quadriplegia

  • Muscular dystrophy

  • Myotonic disorders

  • Anterior horn cell diseases

  • Multiple sclerosis

  • Other disorders of diaphragm

Afflovest Mobile Airway Clearance Therapy

$16,081.00 Regular Price
$11,256.70Sale Price
Excluding Sales Tax |

    Related Products

    bottom of page